Frédérique Menzaghi
2015
In 2015, Frédérique Menzaghi earned a total compensation of $863.8K as Vice President - Research and Development at Cara Therapeutics, a 27% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $120,750 |
|---|---|
| Option Awards | $390,052 |
| Salary | $345,000 |
| Other | $7,950 |
| Total | $863,752 |
Menzaghi received $390.1K in option awards, accounting for 45% of the total pay in 2015.
Menzaghi also received $120.8K in non-equity incentive plan, $345K in salary and $8K in other compensation.
Rankings
In 2015, Frédérique Menzaghi's compensation ranked 8,640th out of 13,638 executives tracked by ExecPay. In other words, Menzaghi earned more than 36.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,640 out of 13,638 | 37th |
Division Manufacturing | 3,301 out of 5,190 | 36th |
Major group Chemicals And Allied Products | 1,203 out of 1,854 | 35th |
Industry group Drugs | 978 out of 1,528 | 36th |
Industry Pharmaceutical Preparations | 767 out of 1,182 | 35th |
Source: SEC filing on April 27, 2016.
Menzaghi's colleagues
We found two more compensation records of executives who worked with Frédérique Menzaghi at Cara Therapeutics in 2015.
News
Cara Therapeutics CEO Derek Chalmers' 2021 pay jumps 250% to $10M
April 22, 2022
Cara Therapeutics CEO Derek Chalmers' 2020 pay slips 15% to $2.9M
April 23, 2021
Cara Therapeutics CEO Derek Chalmers' 2019 pay jumps 23% to $3.4M
April 22, 2020
Cara Therapeutics Chief Medical Officer Joana Goncalves receives $3.7M in 2018
April 24, 2019